Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#1901 most reported symptom for this vaccine
Anticoagulation drug level above therapeutic has been reported 4 times in association with COVID-19 Bivalent (Moderna) vaccination in VAERS. This represents 0.0% of all 42,946 reports for this vaccine.
Among these reports, 1 mentioned death (25.00%) and 4 involved hospitalization (100.0%).
Anticoagulation drug level above therapeutic is the #1901 most frequently reported symptom for COVID-19 Bivalent (Moderna) out of 2434 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 4 reports of Anticoagulation drug level above therapeutic after COVID-19 Bivalent (Moderna) vaccination may seem alarming, but context is critical.
The 25.00% mortality rate among these reports is elevated, but this reflects the severity of the condition itself rather than vaccine causation.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.